 | 178 Mayer Brown partners listed in Best Lawyers in America 2010
4 August 2009 – Mayer Brown, a leading global law firm, announced today that 178 of its lawyers are listed in the 2010 edition of “Best Lawyers in America.” Read >>
| |  | UK Competition Commission Explains its Approach to Remedies
On 26 November 2008, the UK Competition Commission (“CC”) published new guidelines to explain its approach to the selection and implementation of remedies in merger inquiries referred to it by the Office of Fair Trading (“OFT”) under sections 22 or 33 of the Enterprise Act 2002 (“the Act”). Read >>
| | | Mayer, Brown, Rowe & Maw named law firm of the year for pharmaceutical and medical devices law by JUVE
6 November 2006 - International law firm Mayer, Brown, Rowe & Maw LLP has been named "Law Firm of the Year in the field of pharmaceutical and medical devices law" by JUVE, the leading publisher in the German legal market. The firm was presented with the award at the annual JUVE awards ceremony, held in Frankfurt on November 2, 2006. Read >>
| | | 134 Mayer, Brown, Rowe & Maw Lawyers Listed in Chambers USA Guide to Leading Business Lawyers
One hundred thirty-four Mayer, Brown, Rowe & Maw LLP lawyers are listed in the 2006 Chambers USA guide to leading business lawyers. The guide highlights the firm's work in several dozen practice areas throughout the U.S. Mayer, Brown, Rowe & Maw LLP senior counsel Philip Lacovara and partner Robert Baptista were also singled out in receiving prestigious "Chambers USA Awards for Excellence." Read >>
| | | Strengthening Pharmaceutical and Biotechnology Patents
01 March 2005 - All innovative companies recognize the vital interest they have in obtaining patents to protect their intellectual property. However, many companies do not realize that filing a patent application and securing a patent are only the first steps toward the effective protection of intellectual property. Read >>
(A version of this article first appeared in Genetic Engineering News, Volume 25, Number 5, March 1, 2005.) | | | Sheila Dearybury Walcoff Appointed Associate FDA Commissioner for External Relations
7 September 2004 - Dr. Lester M. Crawford, Acting Food and Drug Administration Commissioner, today announced the appointment of Sheila Dearybury Walcoff, Esq., as the new FDA Associate Commissioner for External Relations. Ms. Walcoff is an attorney with extensive legal, strategic, and legislative experience in FDA-related areas. Read >>
| | | Biotech, Pharma and Life Science Newsletter
June 2004 - Federal Health Policy - Heard on Capitol Hill; Reform of European Pharmaceutical Legislation; FDA and SEC Join Forces on Misleading Progress
Claims by Pharmas; FDA Issues Final Rule Requiring Bar Codes; Impact of the New Rules for Technology Licences in Europe; Changes in R&D Tax Credits in the U.K.; U.K. University Victorious in R&D Copyright Case; European Commission Working Paper on Genetic Data; FTC and U.S. Courts Raise Questions About Legality of Pharmaceutical Patent Suit Settlements Read >>
| |
|
